Adult Congenital Heart Disease (ACHD) is a new and rapidly growing field of medicine. Historically, patients born with congenital heart disease did not survive into adulthood. However, with advances in in the care of infants and children with congenital heart disease, an infant born today with congenital heart disease has a greater than 90% chance of surviving to adulthood.
Because of the increase in number and complexity of ACHD patients, the American Board of Internal Medicine established board certification in adult congenital heart disease, with the first examination offered in October 2015. As of July 2019, only practitioners who have completed a two-year ACGME accredited Fellowship will be eligible to take the examination and be board-certified.
Time in our program will be divided between our C.S. Mott Children's Hospital and the Samuel & Jean Frankel Cardiovascular Center - both on the same Michigan Medicine campus.